M&A Deal Summary

Recipharm Acquires Cobra Biomanufacturing

On December 16, 2009, Recipharm acquired life science company Cobra Biomanufacturing

Acquisition Highlights
  • This is Recipharm’s 4th transaction in the Life Science sector.
  • This is Recipharm’s 2nd transaction in the United Kingdom.

M&A Deal Summary

Date 2009-12-16
Target Cobra Biomanufacturing
Sector Life Science
Buyer(s) Recipharm
Deal Type Add-on Acquisition

Target

Cobra Biomanufacturing

Keele, United Kingdom
Cobra Biomanufacturing plc is a provider of biologics and pharmaceuticals contract manufacturing services. Company offers stand-alone services in the areas of cell line development, GMP cell banking, stability testing, protein characterization, bioassays, analytical services.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Recipharm

Stockholm, Sweden

Category Company
Founded 1995
Sector Life Science
Employees7,383
DESCRIPTION

Recipharm is a global Pharma CDMO providing a full-service offering to leading Pharmaceutical companies and Biotechs globally. Recipharm was founded in 1995 and is based in Stockholm, Sweden.


DEAL STATS #
Overall 4 of 18
Sector: Life Science M&A 4 of 12
Type: Add-on Acquisition M&A Deals 2 of 9
Country: United Kingdom M&A 2 of 3
Year: 2009 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-11-17 AstraZeneca - Biotech Laboratory

Södertälje, Sweden

AstraZeneca - Biotech Laboratory engages in research of proteins produced by disease genes.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-01-27 Wasserburger Arzneimittelwerk

Wasserburg, Germany

Wasserburger Arzneimittelwerk GmbH is a well established contract manufacturing organisation specialised in the aseptic filling and lyophilsation of pharmaceuticals into ampoules and vials on behalf of a wide variety of customers.

Buy -